GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow
Not Applicable
- Conditions
- Healthy
- Registration Number
- NCT01988545
- Lead Sponsor
- Zealand University Hospital
- Brief Summary
to investigate the effect of the human incretin hormone GLP-1 on mesenteric blood flow and cardiac parameters
- Detailed Description
to investigate the effect of the human incretin hormone GLP-1 on mesenteric blood flow and cardiac parameters, in healthy subjects, 4 arms, task force monitor
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 8
Inclusion Criteria
- healthy subjects
Exclusion Criteria
- medical conditions
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method blood flow with in 120 minutes blood flow change measured by ultra sound
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Køge Hospital
🇩🇰Køge, State..., Denmark
Køge Hospital🇩🇰Køge, State..., Denmarklasse bremholm, MD, ph.d.Contact004560927874lassebremholm@dadlnet.dkLasse Bremholm, MD, ph.d.Principal Investigator